SLC1A5 and non-small cell lung carcinoma: The targeting of SLC1A5 can be performed by RNA interference and a small molecule inhibitor gamma-L-glutamyl-p-nitrosamides (GPNA) in non-small cell lung cancer (NSCLC) and human bronchial cell lines.